Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory.

Clark EH, Silva CJ, Weiss GE, Li S, Padilla C, Crompton PD, Hernandez JN, Branch OH.

Infect Immun. 2012 Apr;80(4):1583-92. doi: 10.1128/IAI.05961-11. Epub 2012 Jan 17.

2.
4.

Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.

Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.

Infect Immun. 2009 Mar;77(3):1165-74. doi: 10.1128/IAI.01129-08. Epub 2009 Jan 12.

5.

Long-lived Plasmodium falciparum specific memory B cells in naturally exposed Swedish travelers.

Ndungu FM, Lundblom K, Rono J, Illingworth J, Eriksson S, Färnert A.

Eur J Immunol. 2013 Nov;43(11):2919-29. doi: 10.1002/eji.201343630. Epub 2013 Aug 29.

6.

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.

Elias SC, Choudhary P, de Cassan SC, Biswas S, Collins KA, Halstead FD, Bliss CM, Ewer KJ, Hodgson SH, Duncan CJ, Hill AV, Draper SJ.

Immunology. 2014 Apr;141(4):628-44. doi: 10.1111/imm.12226.

7.

Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.

Dobaño C, Quelhas D, Quintó L, Puyol L, Serra-Casas E, Mayor A, Nhampossa T, Macete E, Aide P, Mandomando I, Sanz S, Puniya SK, Singh B, Gupta P, Bhattacharya A, Chauhan VS, Aponte JJ, Chitnis CE, Alonso PL, Menéndez C.

Clin Vaccine Immunol. 2012 Feb;19(2):157-66. doi: 10.1128/CVI.05523-11. Epub 2011 Dec 14.

8.

Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.

Pinder M, Sutherland CJ, Sisay-Joof F, Ismaili J, McCall MB, Ord R, Hallett R, Holder AA, Milligan P.

Infect Immun. 2006 May;74(5):2887-93.

9.

Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1.

Johnson AH, Leke RG, Mendell NR, Shon D, Suh YJ, Bomba-Nkolo D, Tchinda V, Kouontchou S, Thuita LW, van der Wel AM, Thomas A, Stowers A, Saul A, Zhou A, Taylor DW, Quakyi IA.

Infect Immun. 2004 May;72(5):2762-71.

10.

Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru.

Villasis E, Lopez-Perez M, Torres K, Gamboa D, Neyra V, Bendezu J, Tricoche N, Lobo C, Vinetz JM, Lustigman S.

Malar J. 2012 Oct 30;11:361. doi: 10.1186/1475-2875-11-361.

11.

Cellular responses to modified Plasmodium falciparum MSP119 antigens in individuals previously exposed to natural malaria infection.

Okafor CM, Anumudu CI, Omosun YO, Uthaipibull C, Ayede I, Awobode HO, Odaibo AB, Langhorne J, Holder AA, Nwuba RI, Troye-Blomberg M.

Malar J. 2009 Nov 23;8:263. doi: 10.1186/1475-2875-8-263.

12.
13.

B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area.

Dorfman JR, Bejon P, Ndungu FM, Langhorne J, Kortok MM, Lowe BS, Mwangi TW, Williams TN, Marsh K.

J Infect Dis. 2005 May 15;191(10):1623-30. Epub 2005 Apr 13.

PMID:
15838788
14.

Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay.

Miura K, Zhou H, Diouf A, Moretz SE, Fay MP, Miller LH, Martin LB, Pierce MA, Ellis RD, Mullen GE, Long CA.

Clin Vaccine Immunol. 2009 Jul;16(7):963-8. doi: 10.1128/CVI.00042-09. Epub 2009 May 13.

15.

Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.

Noland GS, Hendel-Paterson B, Min XM, Moormann AM, Vulule JM, Narum DL, Lanar DE, Kazura JW, John CC.

Infect Immun. 2008 Dec;76(12):5721-8. doi: 10.1128/IAI.00591-08. Epub 2008 Sep 22.

16.

Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4.

Chang SP, Kayatani AK, Terrientes ZI, Herrera S, Leke RG, Taylor DW.

Malar J. 2010 Jan 13;9:14. doi: 10.1186/1475-2875-9-14.

17.

Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.

McCarra MB, Ayodo G, Sumba PO, Kazura JW, Moormann AM, Narum DL, John CC.

Pediatr Infect Dis J. 2011 Dec;30(12):1037-42. doi: 10.1097/INF.0b013e31822d1451.

18.

Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.

Dodoo D, Atuguba F, Bosomprah S, Ansah NA, Ansah P, Lamptey H, Egyir B, Oduro AR, Gyan B, Hodgson A, Koram KA.

Malar J. 2011 May 1;10:108. doi: 10.1186/1475-2875-10-108.

19.

Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.

Elias SC, Collins KA, Halstead FD, Choudhary P, Bliss CM, Ewer KJ, Sheehy SH, Duncan CJ, Biswas S, Hill AV, Draper SJ.

J Immunol. 2013 Feb 1;190(3):1135-47. doi: 10.4049/jimmunol.1201455. Epub 2013 Jan 4.

20.

Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.

Mamo H, Esen M, Ajua A, Theisen M, Mordmüller B, Petros B.

Malar J. 2013 Feb 5;12:51. doi: 10.1186/1475-2875-12-51.

Supplemental Content

Support Center